CZ ATC C02CA06 · updated 2 Nov 2026
Urapidil shortage in Czechia
Is there a Urapidil shortage in Czechia?
Yes. As of 2 Nov 2026, 2 Urapidil products are reported short in Czechia, the first since 7 Sep 2026. The company estimate for the return is 15 Nov 2026 (latest 30 Apr 2027). Main reason: manufacturing problem.
Also short in Germany, Italy, Austria. All countries.
Affected products in Czechia
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CZ | EBRANTIL RETARD 30MG 30MG CPS PRO 50 | CHEPLAPHARM Arzneimittel GmbH, Greifswald | 7 Sep 2026 | 15 Nov 2026 | Manufacturing problem Výrobní důvody |
| CZ | URAPIDIL MEDREG 60MG 60MG CPS PRO 50 II | MEDREG s.r.o., Praha | 1 Oct 2026 | 30 Apr 2027 | Commercial decision or withdrawal Obchodní/marketingové důvody |
Source
SÚKL (State Institute for Drug Control), market reports. Official list. Products whose latest market report is a supply interruption; one row per SÚKL code.